Schedule of Condensed Balance Sheets |
Condensed balance sheets
| |
As of December 31, | |
| |
2023 | | |
2024 | | |
2024 | |
| |
RMB | | |
RMB | | |
USD | |
ASSETS | |
| | |
| | |
| |
Current assets | |
| | |
| | |
| |
Cash and cash equivalents | |
| 13,423,750 | | |
| 253,708,400 | | |
| 34,757,908 | |
Investments in equity securities | |
| 978,841 | | |
| — | | |
| — | |
Amounts due from subsidiaries | |
| 125,960,969 | | |
| 169,208,479 | | |
| 23,181,467 | |
Amounts due from a related party | |
| — | | |
| — | | |
| — | |
Other current assets | |
| 321,495 | | |
| 330,527 | | |
| 45,282 | |
Total current assets | |
| 140,685,055 | | |
| 423,247,406 | | |
| 57,984,657 | |
Non-current assets: | |
| | | |
| | | |
| | |
Investments in subsidiaries | |
| 2,179,129,452 | | |
| 2,183,092,396 | | |
| 299,082,432 | |
Investments in equity securities | |
| 44,324,789 | | |
| 34,355,681 | | |
| 4,706,709 | |
TOTAL ASSETS | |
| 2,364,139,296 | | |
| 2,640,695,483 | | |
| 361,773,798 | |
| |
| | | |
| | | |
| | |
LIABILITIES AND EQUITY | |
| | | |
| | | |
| | |
Current liabilities: | |
| | | |
| | | |
| | |
Short-term bank loans | |
| 116,800,000 | | |
| — | | |
| — | |
Long -term bank loans, current portion | |
| 200,000 | | |
| 400,000 | | |
| 54,800 | |
Amounts due to subsidiaries | |
| 748,121,016 | | |
| 925,349,353 | | |
| 126,772,340 | |
Total current liabilities | |
| 865,121,016 | | |
| 925,749,353 | | |
| 126,827,140 | |
Non-current liabilities: | |
| | | |
| | | |
| | |
Long-term bank loans, non-current portion | |
| 56,800,000 | | |
| 256,200,000 | | |
| 35,099,256 | |
Total liabilities | |
| 921,921,016 | | |
| 1,181,949,353 | | |
| 161,926,396 | |
Shareholders’ Equity: | |
| | | |
| | | |
| | |
Class A ordinary shares (USD0.50 par value per share; 400,000,000 and 400,000,000 shares authorized as of December 31, 2023 and 2024; 66,780,612 and 66,761,582 shares issued and outstanding as of December 31, 2023 and 2024, respectively) | |
| 222,587,070 | | |
| 222,587,070 | | |
| 30,494,304 | |
Class B ordinary shares (USD0.50 par value per share; 100,000,000 and 100,000,000 shares authorized as of December 31, 2023 and 2024; 34,762,909 and 34,762,909 shares issued and outstanding as of December 31, 2023 and 2024, respectively) | |
| 115,534,210 | | |
| 115,534,210 | | |
| 15,828,122 | |
Treasury stock | |
| (36,677,832 | ) | |
| (37,043,116 | ) | |
| (5,074,886 | ) |
Additional paid-in capital | |
| 1,680,713,349 | | |
| 1,609,972,272 | | |
| 220,565,297 | |
Accumulated losses | |
| (568,339,799 | ) | |
| (458,337,569 | ) | |
| (62,791,989 | ) |
Accumulated other comprehensive income | |
| 28,401,282 | | |
| 6,033,263 | | |
| 826,554 | |
Total Shareholders’ Equity | |
| 1,442,218,280 | | |
| 1,458,746,130 | | |
| 199,847,402 | |
TOTAL LIABILITIES AND EQUITY | |
| 2,364,139,296 | | |
| 2,640,695,483 | | |
| 361,773,798 | |
|
Schedule of Condensed Statements of Operations |
Condensed statements of operations
| |
Year Ended December 31, | |
| |
2022 | | |
2023 | | |
2024 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | | |
USD | |
General and administrative expenses | |
| (6,740,255 | ) | |
| (6,637,389 | ) | |
| (3,495,501 | ) | |
| (478,882 | ) |
Other general expense | |
| (13,944,926 | ) | |
| — | | |
| — | | |
| — | |
Interest income | |
| 1,924 | | |
| 15,128 | | |
| 5,550,006 | | |
| 760,348 | |
Interest expense | |
| (5,192,054 | ) | |
| (4,723,335 | ) | |
| (8,046,920 | ) | |
| (1,102,424 | ) |
Other income (expense) | |
| 22,765,816 | | |
| 19,969,182 | | |
| (4,815,940 | ) | |
| (659,781 | ) |
(Losses) gains on investments in equity securities | |
| (76,105,482 | ) | |
| 7,927,075 | | |
| (11,463,068 | ) | |
| (1,570,434 | ) |
Share of (losses) profit in subsidiaries, net (Note a) | |
| (345,938,204 | ) | |
| 252,765,647 | | |
| 132,273,653 | | |
| 18,121,416 | |
Net (loss) income | |
| (425,153,181 | ) | |
| 269,316,308 | | |
| 110,002,230 | | |
| 15,070,243 | |
Other comprehensive losses, net of tax | |
| | | |
| | | |
| | | |
| | |
- Foreign currency translation adjustments | |
| (11,361,872 | ) | |
| 672,112 | | |
| (22,374,019 | ) | |
| (3,065,228 | ) |
- Unrealized (losses) on available-for-sale investments | |
| (2,786,931 | ) | |
| (2,934 | ) | |
| 6,000 | | |
| 822 | |
Comprehensive (loss) income | |
| (439,301,984 | ) | |
| 269,985,486 | | |
| 87,634,211 | | |
| 12,005,837 | |
|
Schedule of Condensed Statements of Cash Flows |
Condensed statements of cash flows
| |
Year Ended December 31, | |
| |
2022 | | |
2023 | | |
2024 | | |
2024 | |
| |
RMB | | |
RMB | | |
RMB | | |
USD | |
Net cash used in operating activities | |
| (4,198,307 | ) | |
| (12,424,134 | ) | |
| (5,660,966 | ) | |
| (775,549 | ) |
Net cash provided by investing activities | |
| (156,276,810 | ) | |
| (352,234,205 | ) | |
| 101,781,775 | | |
| 13,944,046 | |
Net cash provided by financing activities | |
| 155,679,057 | | |
| 362,690,064 | | |
| 143,247,486 | | |
| 19,624,825 | |
| |
| | | |
| | | |
| | | |
| | |
Effect of exchange rate changes on cash and cash equivalents and restricted cash | |
| (2,025,056 | ) | |
| (396,838 | ) | |
| 916,355 | | |
| 125,540 | |
| |
| | | |
| | | |
| | | |
| | |
Net decrease in cash and cash equivalents and restricted cash | |
| (6,821,116 | ) | |
| (2,365,113 | ) | |
| 240,284,650 | | |
| 32,918,862 | |
Cash and cash equivalents and restricted cash at beginning of the year | |
| 22,609,979 | | |
| 15,788,863 | | |
| 13,423,750 | | |
| 1,839,046 | |
Cash and cash equivalents and restricted cash at end of the year | |
| 15,788,863 | | |
| 13,423,750 | | |
| 253,708,400 | | |
| 34,757,908 | |
|